查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球氣管插管市場
市場調查報告書
商品編碼
1153800

2022-2029 年全球氣管插管市場

Global Endotracheal Tube Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2022 年至 2029 年），氣管插管的全球市場規模預計將以 6.00% 的複合年增長率增長。

氣管插管是一種柔性塑料管，通過口腔進入氣管，氣管與呼吸機相連，為肺部供氧。當患者無法自行呼吸時，會插入氣管插管。插入管子的過程稱為氣管插管。氣管插管大多由聚氯乙烯 (PVC) 製成，並且只能一次性使用。

市場動態

全球氣管插管市場主要受肺栓塞、慢性阻塞性肺病等呼吸系統疾病發病率增加、手術過程中麻醉活動次數增多、麻醉首選喉罩優於 ETT 的趨勢上升、術中插管需求增加所推動重傷和全球手術數量的增加是預測期內推動市場的因素。

慢性呼吸道疾病患病率的增加預計將推動市場增長。

根據美國疾病控制與預防中心的數據，慢性呼吸道疾病 (CRD) 會損害氣道和其他肺部結構。慢性阻塞性肺病 (COPD)、哮喘、職業性肺病和肺動脈高壓是最常見的疾病。除了煙草煙霧，空氣污染、職業化學品和粉塵以及兒童期反復發作的下呼吸道疾病也是危險因素。哮喘影響全球約3億人，在美國等發達國家更為普遍。

此外，根據 CDC 的 2020 年全國健康訪談調查 (NHIS)，估計美國有 2520 萬成年人（包括 420 萬兒童）患有哮喘。 2020 年，包括約 180 萬兒童在內的超過 1030 萬哮喘患者報告至少發生過一次哮喘發作。因此，伴有急性呼吸困難的哮喘患者首選氣管插管。因此，從上述描述來看，它有望成為市場增長的引擎。

缺乏熟練的氣管插管專業人員預計會阻礙市場增長。

氣管插管手術需要高技能的麻醉師和訓練有素的護士。缺乏關於正確選擇立即治療的知識會對患者狀況產生不利影響，增加恢復時間，並增加直接和間接成本。在緊急情況下，嚴重損傷的診斷和處理不當會導致受傷部位畸形、功能障礙，甚至導致患者死亡。據世界衛生組織稱，估計約有 70% 的慢性阻塞性肺病患者由於對該病缺乏認識而未被確診。此外，與慢性阻塞性肺病一樣，哮喘未得到充分診斷和治療（約 50% 的哮喘患者）。這些因素阻礙了預測期內的市場增長。

此外，麻醉師和護理人員的短缺是世界各國關注的主要問題之一。這種短缺直接影響醫療機構提供外科和急救護理的效率和能力，進一步阻礙了對這些手術中使用的氣管插管設備的需求。

COVID-19 影響分析

COVID-19 疫情對氣管插管行業產生了積極影響。由於呼吸窘迫是感染的明確指標，COVID-19 的出現顯著增加了對氣管插管的需求，推動了市場的增長。對於 COVID 患者的呼吸衰竭，美國支氣管和介入醫學學會建議進行開放式外科氣管切開術 (OST) 或經皮擴張氣管切開術。此外，大流行為緊急產品批准鋪平了道路。例如，總部位於美國的生物技術公司 N8 已獲得加拿大衛生部的批准，可以緊急使用 Therashield 氣管導管對 COVID-19 患者進行機械通氣。此外，據說大型私立和公立醫院的呼吸設備引進率相對較高，而小型醫院和診所的引進率較低。基於上述情況，市場有望在預測期內活躍起來。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 由於慢性呼吸道疾病的增加，預計該市場將會擴大。
    • 約束因素
      • 缺乏精通氣管插管的專業人員預計會阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 搬運工的五種力量
  • 供應鏈
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 普通氣管插管（標準管）
  • 加強型/鎧裝氣管插管
  • 預製氣管插管
  • RAE 管
  • 雙腔氣管插管
  • 其他特殊氣管插管
      • 微型喉氣管插管
      • 激光氣管插管
      • 其他（聲門下抽吸氣管插管）

第 8 章插管類型

  • 氣管插管
  • 鼻氣管

第 9 章按應用

  • 治療
  • 緊急處理
  • 其他

第 10 章最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第13章公司簡介

  • ConvaTec Inc.
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Bactiguard AB
  • Teleflex Incorporated
  • Medtronic Plc.（Covidien）
  • Smith's Group plc.（Smiths Medical）
  • ROYAX, S.R.O
  • Medline Industries, Inc.
  • Eakin Healthcare Group（Armstrong Medical Ltd）
  • Venner Medical
  • P3 Medical Limited

第14章 世界氣管插管-DataM

簡介目錄
Product Code: DMMD1149

Market Overview

The global endotracheal tube size was valued US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 6.00% during the forecast period (2022-2029).

An endotracheal tube is a flexible plastic tube that is placed through the mouth into the trachea which is connected to a ventilator to deliver oxygen to the lungs. The tube is inserted when a patient is unable to breathe on their own. The process of inserting the tube is called endotracheal intubation. Endotracheal tubes are mostly made of polyvinyl chloride (PVC) and can be used only once.

Market Dynamics

The global endotracheal tube market is primarily driven by the increasing incidence of respiratory diseases such as pulmonary embolism, chronic obstructive pulmonary disorders and number of anesthesia activity during surgeries, etc., growing preference for anesthesia laryngeal masks over ETTs, increasing need for intubation during severe injuries, and rising surgeries across the globe are the factors to drive the market in the forecast period.

The increasing prevalence of chronic respiratory diseases is expected to drive market growth.

According to the Centers for Disease Control and Prevention, chronic respiratory disorders (CRDs) impair the airways and other lung structures. Chronic obstructive pulmonary disease (COPD), asthma, occupational lung disorders, and pulmonary hypertension are some of the most frequent. Air pollution, occupational chemicals and dust, and repeated lower respiratory illnesses during childhood are also risk factors in addition to tobacco smoke. Asthma affects around 300 million individuals worldwide, which is more prevalent in industrialized countries such as the United States.

Additionally, according to the CDC's 2020 National Health Interview Surveys (NHIS), an estimated 25.2 million adults, including 4.2 million children, have asthma in the United States. In 2020, more than 10.3 million asthmatics, including approximately 1.8 million children, reported having one or more asthma attacks. Therefore, orotracheal intubation is preferred for asthmatic patients in acute respiratory distress. Thus, from the above statements, the market is expected to drive market growth.

The lack of skilled professionals for endotracheal intubation is expected to hamper the market growth.

Endotracheal tube procedures require highly skilled anesthetists and trained nurses. The lack of knowledge regarding the right choice of immediate treatment can adversely affect the patient's condition, increase recovery time, and surge direct and indirect expenses. In emergency conditions, the improper diagnosis and treatment of serious injuries can cause deformities and lead to the dysfunction of the injured area or patient death. According to the WHO, it is estimated that around 70% of COPD patients are underdiagnosed owing to the lack of awareness about the disease. Like COPD, asthma is also highly underdiagnosed and undertreated (in around 50% of asthmatics). Thus these factors are hampering the market growth in the forecast period.

Moreover, the shortage of anesthetists and paramedics has become one of the key concerns for countries across the globe. The shortage has directly impacted the efficiency and capabilities of healthcare settings to provide surgical and emergency care, further hampering the demand for endotracheal tube devices used across these procedures.

COVID-19 Impact Analysis

The COVID-19 epidemic had a positive impact on the endotracheal tube industry. The advent of COVID-19 has significantly increased the demand for endotracheal tubes, as breathing trouble is a clear indicator of infection, which has driven market growth. In the event of respiratory failure in COVID patients, the American Association for Bronchology and Interventional Pulmonology recommends conducting Open Surgical Tracheostomy (OST) or percutaneous dilatational tracheostomy. Moreover, the pandemic paved the way for emergency product approvals. For instance, a U.S.-based biotech firm, N8, secured emergency use authorization from Health Canada For its CeraSheild Endotracheal Tubes in mechanically ventilated COVID-19 patients. In addition, large private and public hospitals relatively have higher uptake of respiratory devices, and small hospitals and clinics have a low rate of product uptake. Thus, from the above statements, the market got driven in the forecast period.

Segment Analysis

Ambulatory surgical centers (ASCs) segment is expected to hold the largest market share in endotracheal tube

The ambulatory surgical centers (ASCs) segment accounted for the largest market share in 2021. With rapid technological advancements in the healthcare sector, 60% of all surgeries can be performed at ambulatory surgical units, creating a surging demand for surgical procedures in emerging economies such as India. ASCs are expected to reduce the average cost of treatment by 70% when compared to the cost of inpatient surgery. This factor is important for a country like India, with 1.4 billion population, in which a significant number of people can earn less than $ 2 a day. Moreover, many Central government policies under the Ministry of Ayush facilitate people under the poverty line by providing them with medical insurance.

Additionally, in the U.S., Medicare is the largest single-payer of clinical services. Medicare spending accounts for more than 40% of the clinical expenditures of patients. Medicaid payments are divided into three main categories, the traditional home health benefit (mandatory), the personal healthcare option, and home and community-based waivers as an optional program. These three healthcare service categories collectively hold a small share of total Medicaid payments. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global endotracheal tube

North America region accounted for the largest market share in 2021. Over 40 million endotracheal intubations are performed annually in the U.S., making it the single largest interventional procedure. Nearly 2 million of those procedures are complex and challenging to perform. The LightSpeed Intubation System enables quicker and safer positioning of the endotracheal tube without losing control of the airway. Due to the high number of such cases, the demand for airway management devices is increasing globally.

Moreover, the presence of major regional players contributed to market growth. For instance, on January 14, 2020, Smiths Medical launched a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio to its family of tracheostomy tubes. Smith's Medical BLUselect tracheotomy tubes, BLUperc and BLUgriggs percutaneous tracheostomy kits and trays. Additionally, many players in the market are developing products with antimicrobial and anti-coagulant coating properties that can reduce VAP. For instance, Medtronic Shiley Evac endotracheal tubes have been stated to reduce VAP by 50.0%. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the endotracheal tube are: ConvaTec Inc., Bactiguard AB, Teleflex Incorporated, Medtronic Plc. (Covidien), Smiths Group plc.(Smiths Medical), ROYAX, S.R.O, Medline Industries, Inc., Eakin Healthcare Group(Armstrong Medical Ltd), Venner Medical and P3 Medical Limited

In January 20, 2022, P3 Medical is set to showcase a device designed to tighten infection control in airway management at Arab Health 2022. The NeVap Aspire Subglottic Suction Endotracheal tube (ASSET) is the only FDA-cleared multiport suction breathing tube. Clinicians have developed it to make mechanical ventilation safer by preventing the risks of ventilator-associated pneumonia.

Covidien:

Overview:

Covidien was an Irish-headquartered global healthcare product company and manufacturer of medical devices and supplies. Covidien became an independent publicly traded company after being spun off from Tyco International in 2007. Covidien's portfolio consists of medical devices, including surgical, respiratory, patient monitoring, gastrointestinal, lung health, and renal care products. The Medical Devices segment includes developing, manufacturing and selling endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. In June 2014, Covidien plc was acquired by Medtronic for $42.9 billion in Cash and Stock. With its expanded portfolio of innovative products and services, this acquisition will allow Medtronic to reach more patients.

Product Portfolio:

Shiley Reinforced Oral/Nasal Endotracheal Tube: The Shiley oral/nasal endotracheal tube reinforced features a soft, flexible PVC tube with spiral-wound reinforcing wire designed to help reduce kinking.

The global endotracheal tube report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing prevalence of chronic respiratory diseases is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The lack of skilled professionals for endotracheal intubation is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Regular Endotracheal Tube (Standard Tubes)*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Reinforced/Armored Endotracheal Tube
  • 7.4. Preformed Endotracheal Tube
  • 7.5. RAE tube
  • 7.6. Double lumen Endotracheal Tube
  • 7.7. Other Specialty Endotracheal Tube
      • 7.7.1.1. Microlaryngeal Endotracheal Tube
      • 7.7.1.2. Laser Endotracheal Tube
      • 7.7.1.3. Others (Subglottic Suctioning Endotracheal Tubes)

8. By Intubation Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 8.1.2. Market Attractiveness Index, By Intubation Type
  • 8.2. Orotracheal*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Nasotracheal

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Therapy*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Emergency Treatment
  • 9.4. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user
  • 10.2. Hospitals*
      • 10.2.1.1. Introduction
      • 10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialty Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Intubation Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. ConvaTec Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Bactiguard AB
  • 13.3. Teleflex Incorporated
  • 13.4. Medtronic Plc.(Covidien)
  • 13.5. Smith's Group plc.(Smiths Medical)
  • 13.6. ROYAX, S.R.O
  • 13.7. Medline Industries, Inc.
  • 13.8. Eakin Healthcare Group(Armstrong Medical Ltd)
  • 13.9. Venner Medical
  • 13.10. P3 Medical Limited

LIST NOT EXHAUSTIVE

14. Global Endotracheal Tube - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us